300039.SZ
Shanghai Kaibao Pharmaceutical Co., Ltd.
SZSE · Healthcare · C 制造业 · CN
CNY 5.29
−4.51%Year over year
Reported trailing growth
- Revenue
- -26.0%
- EBITDA
- —
- EBIT
- -32.2%
- EPS
- -30.2%
- Free cash flow
- +11.0%
- Operating cash flow
- -35.6%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +1.0%
- EBITDA
- +11.5%
- EBIT
- +12.5%
- Net income
- +13.4%
- EPS
- +13.4%
- Free cash flow
- -16.1%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026